Advertisement

Non-invasive ventilator SwasthVayu's clinical trial to start soon: NAL

Follow The Hawk on Google News+ Follow

Advertisement

New Delhi: The National Aerospace Laboratories (NAL) on Thursday said it would soon start human clinical trial of its indigenously developed non-invasive ventilator "SwasthVayu" to treat COVID-19 patients.

The trial of the first Made in India non-invasive ventilator would begin at the Manipal Hospital, which also collaborated in its development in 'record' 36 days, the NAL said in a statement here.

Advertisement

The device can be used for COVID patients and also support those suffering from other respiratory disorders and heart failure, it said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

NAL had in May last announced the development of the ventilator which was simple to use without any specialised nursing and cost effective, compact and configured with majority of indigenous components.

Since then it had been tested on artificial lung models with successful results, the institute said.

Advertisement

SwastVayu was developed by the NAL, a part of the Council of Scientific and Industrial Research (CSIR), in scientific and medical knowledge collaboration with Dr Satyanarayana Mysore, head of the Pulmonology Respiratory and Sleep Medicine at Manipal Hospital, and Dr Anurag Agarwal, Director of CSIR-Institute of Genomics and Integrative Biology (IGIB).

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

"The Ethics Committee, and the scientific committee at Manipal Hospital, Bengaluru has scrutinized and approved the device for clinical trials under Dr Satyanarayana, Head of Pulmonology and Sleep Medicine as the Principal Investigator," the statement said.

It added that there was a compelling need for indigenous ventilators to mitigate the acute shortage of ventilators.

The statement quoted Dr Satyanarayana as saying that the device will also be a bonanza post-pandemic for treating sleep-disordered breathing including obstructive sleep apnea and other sleep apnea.

The clinical trial will begin shortly and for now, the focus will be limited to its successful completion, he said.

Chief scientist and Head Electronics Division of NAL Dr C M Ananda said the device had been subjected to trials on artificial lung models and has successfully passed stringent electrical safety, performance, calibration, bio-compatibility tests at National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited laboratory.

According to the NAL, SwasthVayu is equipped with advanced features like Bi-level mode (BiPAP), Continuous Positive Airway Mode (CPAP), Spontaneous modes and 3D printed HEPA-T filter adapter connected directly to the non-ventilated mask.

—PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST